Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

X-TRAP: Phase I/II Study of Capecitabine Plus Aflibercept in Metastatic Colorectal Cancer

NCT01661972 is registered in ClinicalTrials.gov with John Strickler, M.D. as lead sponsor.

NCT NCT01661972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
X-TRAP: Phase I/II Study of Capecitabine Plus Aflibercept in Metastatic Colorectal Cancer
Lead sponsor
John Strickler, M.D.
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2012
Completion date
June 12, 2016
Enrollment
63 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer